Showing results (531-540 of 632) with videos related to

Sort By:
Pageof 64
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
Cancer|April 8, 2015
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trialDeborah W Bruner, Daniel Hunt, Jeff M Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.
The Journal of Urology|February 16, 2005
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz, Howard D Thames, Deborah A Kuban, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 TrialJohn J Coen, Joseph P Rodgers, Philip J Saylor, et al.
The Journal of Urology|January 15, 2018
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care OptionsMartin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
The Journal of Urology|December 6, 2017
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care OptionsMartin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJohn J Coen, Peixin Zhang, Philip J Saylor, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2000
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406J M Michalski, J A Purdy, K Winter, et al.
Cancer|February 26, 2013
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancerPhillip J Gray, Jonathan J Paly, Beow Y Yeap, et al.
Pageof 64